J Wrist Surg
DOI: 10.1055/a-2698-9954
Scientific Article

Retrospective Review of Pyrocarbon Hemiarthroplasty for Carpometacarpal Arthritis: An Examination of Long-Term Outcomes and Complications

Authors

  • Matthew M. Rode

    1   Alix School of Medicine, Mayo Clinic, Rochester, Minnesota, United States
  • Barbara L. Mullen

    2   Department of Plastic and Reconstructive Surgery, Mayo Clinic, Rochester, Minnesota, United States
  • Samuel N. Schrader

    3   Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, United States
  • Marco Rizzo

    3   Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, United States
  • Steven L. Moran

    2   Department of Plastic and Reconstructive Surgery, Mayo Clinic, Rochester, Minnesota, United States

Funding Information None.
Preview

Abstract

Background

Thumb carpometacarpal (CMC) arthritis is a common and sometimes debilitating condition with a variety of surgical treatments. Pyrocarbon thumb CMC hemiarthroplasty is one option, which has demonstrated promise; however, no long-term outcomes have been reported.

Materials and Methods

We performed a retrospective institutional review of 106 primary thumb CMC pyrocarbon hemiarthroplasties with a minimum of 1 year, median 6.1-year follow-up. We analyzed rates of pain relief, reoperation, and implant failure as well as biomechanical, radiographic, and patient-reported outcomes.

Results

Pain was significantly decreased after surgery. Radial and palmar abduction were modestly improved postoperatively (increased from 40–50 degrees). Implants showed high rates of radiographic osteolysis (53%) and subsidence (44%). Two-, 5-, and 10-year rates of reoperation (18, 21, 21%) and implant removal (15, 19, and 19%), respectively.

Conclusions

Pyrocarbon thumb CMC hemiarthroplasty provides high rates of pain relief and preservation of pinch and grip strength. Patients had modest improvement in radial and palmar abduction; however, hemiarthroplasty was associated with moderate rates of reoperation and implant revision.

Level of Evidence

Therapy Level IV.

Ethical Approval

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5).


Informed Consent

Informed consent was obtained from all individual participants included in the study.


Supplementary Material



Publication History

Received: 07 June 2025

Accepted: 01 September 2025

Article published online:
29 September 2025

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA